Jiang T, Li S, Tang L, Tan Y, Ouyang W
Cent Eur J Immunol. 2025; 49(4):404-424.
PMID: 39944257
PMC: 11811719.
DOI: 10.5114/ceji.2024.145013.
Sun F, Wang J, Yang Y, Dong Q, Jia L, Hu W
Cell Mol Life Sci. 2024; 81(1):387.
PMID: 39249529
PMC: 11383905.
DOI: 10.1007/s00018-024-05420-y.
Ji G, Zhang Z, Wang X, Guo Q, Zhang E, Li C
Sci Rep. 2024; 14(1):20035.
PMID: 39198546
PMC: 11358327.
DOI: 10.1038/s41598-024-70281-1.
Wilhelmsen I, Combriat T, Dalmao-Fernandez A, Stokowiec J, Wang C, Olsen P
Stem Cell Res Ther. 2024; 15(1):223.
PMID: 39044210
PMC: 11267759.
DOI: 10.1186/s13287-024-03852-8.
Chen X, Wang Y, Wan J, Dou X, Zhang C, Sun M
Biomol Biomed. 2024; 24(6):1806-1815.
PMID: 38943679
PMC: 11496877.
DOI: 10.17305/bb.2024.10530.
Persistent gene expression and DNA methylation alterations linked to carcinogenic effects of dichloroacetic acid.
Carswell G, Chamberlin J, Bennett B, Bushel P, Chorley B
Front Oncol. 2024; 14:1389634.
PMID: 38764585
PMC: 11099211.
DOI: 10.3389/fonc.2024.1389634.
TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis.
Isaac R, Bandyopadhyay G, Rohm T, Kang S, Wang J, Pokhrel N
Cell Metab. 2024; 36(5):1030-1043.e7.
PMID: 38670107
PMC: 11113091.
DOI: 10.1016/j.cmet.2024.04.003.
Resveratrol protects against Schistosoma mansoni-induced liver fibrosis by targeting the Sirt-1/NF-κB axis.
Mostafa D, Eissa M, Ghareeb D, Abdulmalek S, Hewedy W
Inflammopharmacology. 2023; 32(1):763-775.
PMID: 38041753
PMC: 10907480.
DOI: 10.1007/s10787-023-01382-y.
Linseed oil attenuates fatty liver disease in mice fed a high-carbohydrate diet.
Godoy G, Bernardo C, Casagrande L, Sergio M, Zanoni J, Perles J
Braz J Med Biol Res. 2023; 56:e12927.
PMID: 37703111
PMC: 10496762.
DOI: 10.1590/1414-431X2023e12927.
Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis.
Rho H, Terry A, Chronis C, Hay N
Cell Metab. 2023; 35(8):1406-1423.e8.
PMID: 37463576
PMC: 11748916.
DOI: 10.1016/j.cmet.2023.06.013.
Polymer-Functionalized Mitochondrial Transplantation to Fibroblasts Counteracts a Pro-Fibrotic Phenotype.
Baudo G, Wu S, Massaro M, Liu H, Lee H, Zhang A
Int J Mol Sci. 2023; 24(13).
PMID: 37446100
PMC: 10342003.
DOI: 10.3390/ijms241310913.
Treatment of liver fibrosis: Past, current, and future.
Zhang C, Liu S, Yang M
World J Hepatol. 2023; 15(6):755-774.
PMID: 37397931
PMC: 10308286.
DOI: 10.4254/wjh.v15.i6.755.
Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism.
Zhang Z, Shang J, Yang Q, Dai Z, Liang Y, Lai C
J Nanobiotechnology. 2023; 21(1):29.
PMID: 36698192
PMC: 9878808.
DOI: 10.1186/s12951-023-01788-4.
Danshensu attenuated lipopolysaccharide-induced LX-2 and T6 cells activation through regulation of ferroptosis.
Wang C, Su Z, Xu J, Ko C
Food Sci Nutr. 2023; 11(1):344-349.
PMID: 36655094
PMC: 9834887.
DOI: 10.1002/fsn3.3065.
Oxidative stress-mediated mitochondrial fission promotes hepatic stellate cell activation via stimulating oxidative phosphorylation.
Zhou Y, Long D, Zhao Y, Li S, Liang Y, Wan L
Cell Death Dis. 2022; 13(8):689.
PMID: 35933403
PMC: 9357036.
DOI: 10.1038/s41419-022-05088-x.
Modulation of hepatic stellate cells by Mutaflor probiotic in non-alcoholic fatty liver disease management.
Hany N, Eissa S, Basyouni M, Hasanin A, Aboul-Ela Y, Elmagd N
J Transl Med. 2022; 20(1):342.
PMID: 35907883
PMC: 9338485.
DOI: 10.1186/s12967-022-03543-z.
miR-146b-5p activation of hepatic stellate cells contributes to the progression of fibrosis by directly targeting HIPK1.
Xie J, Cheng N, Huang Z, Shu X, Xiang T
Exp Ther Med. 2022; 24(2):537.
PMID: 35837064
PMC: 9257962.
DOI: 10.3892/etm.2022.11474.
Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist.
Phillips B, Lantier L, Engman C, Garciafigueroa Y, Singhi A, Trucco M
Cardiovasc Diabetol. 2022; 21(1):130.
PMID: 35831885
PMC: 9277870.
DOI: 10.1186/s12933-022-01564-y.
Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD).
Subramanian P, Hampe J, Tacke F, Chavakis T
Int J Mol Sci. 2022; 23(13).
PMID: 35805998
PMC: 9266719.
DOI: 10.3390/ijms23136996.
Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway.
Yu Q, Dai W, Ji J, Wu L, Feng J, Li J
J Cell Mol Med. 2022; 26(10):3031-3045.
PMID: 35429101
PMC: 9097842.
DOI: 10.1111/jcmm.17322.